CMS

DRUG3 trials

Sponsors

Hoffmann-La Roche, Zambon SpA

Conditions

Healthy VolunteerNon Cystic Fibrosis Bronchiectasis

Phase 1

A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS)

CompletedNCT02156323

Hoffmann-La RocheHealthy Volunteer

Start: 2014-07-31End: 2015-03-31Updated: 2016-11-02

Phase 3

Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)

CompletedNCT03093974

Zambon SpANon Cystic Fibrosis Bronchiectasis

Start: 2017-06-06End: 2021-04-09Updated: 2023-11-15

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

TerminatedNCT03460704

Zambon SpANon Cystic Fibrosis Bronchiectasis

Start: 2018-01-29End: 2022-03-15Updated: 2023-12-29